WAVEcommunity

We lead the advancement of breakthroughs in life science research

Read more about our network of partners and customers worldwide

It's how we work together

leadXpro

Headquartered in Villigen, home of the Paul Scherer Institute in Switzerland, leadXpro is a lead discovery company committed to the application of biophysical and structure-based methods for membrane protein drug discovery.

2bind

Headquartered in Regensburg, 2bind offers tailor-made service packages for protein- and RNA-based drug discovery. With essential and cutting-edge biophysical tools 2bind can answer practically every question for binding affinity, kinetics, thermodynamics, stoichiometry, protein stability, and many more.

University of Zurich

Together with Markus Seeger (University of Zurich) system can be used to understand the binding dynamics of Sybody™ candidates to the receptor binding domain (RBD) of SARS-CoV-2, both provided by Linkster Therapeutics AG and the University of Zürich.

Robust with multiple applications. Dependable results with high sensitivity

James Schouten, PhD,

Principal Scientist at Mologic

The Creoptix’ WAVE technology aids us best in discovering better drug molecules

Nicolas Bocquet, PhD,

Senior Scientist at leadXpro

This is the best instrument we have come across for label-free small molecule research

Robert Horvath, PhD,

Head of Nanobiosensorics Laboratory at MFA Budapest

Continue exploring the WAVEsystem

• Real Samples, Real Data

  The Creoptix™ WAVEsystem

  Confidently detect and quantify biological interactions in real-time, for high-quality kinetic data across a broader range of samples than traditional equipment.